Investing.com -- Hyperfine, Inc. (NASDAQ: HYPR) stock climbed 4.6% following the announcement of promising early results from its CARE PMR study presented at the 2025 Alzheimer’s Association ...

The human brain evolves at a breathtaking pace in early life, but capturing this transformation has long challenged ...

"Because I had waited so long, the infection had spread to my bloodstream and now my organs had begun to fail." ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

With the UVEye system, more than a dozen cameras capture every angle of the vehicle, even the undercarriage, as it’s driven through a high-tech arch.

Army Director-General Medical Services visited the hospital to assess infrastructure, medical capabilities, and recent ...

Molecular breast imaging ("MBI”) is an emerging modality that uses gamma radiation and injectable radioactive tracers. It is typically reserved for investigational diagnostic imaging and delivers a ...

Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa)  is no exception. A ...

The site of consciousness is a historical debate among scholars; however, new data revealed that the body and brain may play ...

A groundbreaking AI tool could soon help prevent sudden cardiac deaths by accurately identifying high-risk patients with a ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...